会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 35. 发明申请
    • Process for Producing Cyclic Compounds
    • 生产环状化合物的方法
    • US20070173643A1
    • 2007-07-26
    • US11688022
    • 2007-03-19
    • Todd WerpyJohn FryeJames WhiteJohnathan HolladayAlan Zacher
    • Todd WerpyJohn FryeJames WhiteJohnathan HolladayAlan Zacher
    • C07D207/267C07D223/10C07D205/02
    • C07D207/404
    • The invention includes methods of processing an initial di-carbonyl compound by conversion to a cyclic compound. The cyclic compound is reacted with an alkylating agent to form a derivative having an alkylated ring nitrogen. The invention encompasses a method of producing an N-alkyl product. Ammonia content of a solution is adjusted to produce a ratio of ammonia to di-carboxylate compound of from about 1:1 to about 1.5:1. An alkylating agent is added and the initial compound is alkylated and cyclized. The invention includes methods of making N-methyl pyrrolidinone (NMP). Aqueous ammonia and succinate is introduced into a vessel and ammonia is adjusted to provide a ratio of ammonia to succinate of less than 2:1. A methylating agent is reacted with succinate at a temperature of from greater than 100° C. to about 400° C. to produce N-methyl succinimide which is purified and hydrogenated to form NMP.
    • 本发明包括通过转化为环状化合物来处理初始二羰基化合物的方法。 环状化合物与烷基化剂反应形成具有烷基化环氮的衍生物。 本发明包括生产N-烷基产物的方法。 调节溶液的氨含量以产生约1:1至约1.5:1的氨与二羧酸酯化合物的比例。 加入烷基化剂并将该初始化合物烷基化并环化。 本发明包括制备N-甲基吡咯烷酮(NMP)的方法。 将氨水和琥珀酸钠引入容器中,并调节氨以提供小于2:1的氨与琥珀酸的比例。 甲基化剂与琥珀酸酯在大于100℃至约400℃的温度下反应,生成N-甲基琥珀酰亚胺,将其纯化并氢化形成NMP。
    • 38. 发明授权
    • Detection of markers in nascent proteins
    • 新生蛋白中标记物的检测
    • US07211394B2
    • 2007-05-01
    • US11145781
    • 2005-06-06
    • Kenneth J. RothschildJerzy OlejnikSanjay M. Sonar
    • Kenneth J. RothschildJerzy OlejnikSanjay M. Sonar
    • C12Q1/68
    • C07D207/404A61K38/00A61K41/0042C07C205/45C07C205/57C07D311/16C07D405/12C07D495/04C07H19/04C07H21/00C07K1/1077C07K1/13C12P21/00C12Q1/68G01N33/532G01N33/582
    • The invention is directed to methods for the non-radioactive labeling, detection, quantitation and isolation of nascent proteins translated in a cellular or cell-free translation system. tRNA molecules are misaminoacylated with non-radioactive markers which may be non-native amino acids, amino acid analogs or derivatives, or substances recognized by the protein synthesizing machinery. Markers may comprise cleavable moieties, detectable labels, reporter properties wherein markers incorporated into protein can be distinguished from unincorporated markers, or coupling agents which facilitate the detection and isolation of nascent protein from other components of the translation system. The invention also comprises proteins prepared using misaminoacylated tRNAs which can be utilized in pharmaceutical compositions for the treatment of diseases and disorders in humans and other mammals, and kits which may be used for the detection of diseases and disorders.
    • 本发明涉及用于在细胞或无细胞翻译系统中翻译的新生蛋白的非放射性标记,检测,定量和分离的方法。 tRNA分子被非放射性标记物错氨基酰化,其可以是非天然氨基酸,氨基酸类似物或衍生物,或由蛋白质合成机理识别的物质。 标记可以包含可切割部分,可检测标记,报告基因特性,其中掺入蛋白质的标记可以与非组合标记物或促进从翻译系统的其他组分检测和分离新生蛋白质的偶联剂区别。 本发明还包括使用可用于治疗人类和其他哺乳动物疾病和病症的药物组合物中的使用错氨基酰化tRNA制备的蛋白质,以及可用于检测疾病和病症的试剂盒。
    • 39. 发明授权
    • Detection of disease related genes
    • 检测疾病相关基因
    • US07169558B2
    • 2007-01-30
    • US10401251
    • 2003-03-27
    • Kenneth J. RothschildSanjay M. SonarJerzy Olejnik
    • Kenneth J. RothschildSanjay M. SonarJerzy Olejnik
    • C12Q1/68
    • A61K41/0042A61K38/00C07C205/45C07C205/57C07D207/404C07D311/16C07D405/12C07D495/04C07H19/04C07H21/00C07K1/1077C07K1/13C12P21/00C12Q1/6883G01N33/58
    • The invention is directed to methods for the non-radioactive labeling, detection, quantitation and isolation of nascent proteins translated in a cellular or cell-free translation system. tRNA molecules are misaminoacylated with non-radioactive markers which may be non-native amino acids, amino acid analogs or derivatives, or substances recognized by the protein synthesizing machinery. Markers may comprise cleavable moieties, detectable labels, reporter properties wherein markers incorporated into protein can be distinguished from unincorporated markers, or coupling agents which facilitate the detection and isolation of nascent protein from other components of the translation system. The invention also comprises proteins prepared using misaminoacylated tRNAs which can be utflized in pharmaceutical compositions for the treatment of diseases and disorders in humans and other maninials, and kits which may be used for the detection of diseases and disorders.
    • 本发明涉及用于在细胞或无细胞翻译系统中翻译的新生蛋白的非放射性标记,检测,定量和分离的方法。 tRNA分子被非放射性标记物错氨基酰化,其可以是非天然氨基酸,氨基酸类似物或衍生物,或由蛋白质合成机理识别的物质。 标记可以包含可切割部分,可检测标记,报告基因特性,其中掺入蛋白质的标记可以与非组合标记物或促进从翻译系统的其他组分检测和分离新生蛋白质的偶联剂区别。 本发明还包括使用错氨基酰化tRNA制备的蛋白质,其可以在药物组合物中被用于治疗人类和其他肌肉疾病和病症,以及可用于检测疾病和病症的试剂盒。